BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36277719)

  • 1. Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice.
    van Beek DJ; Pieterman CRC; Wessels FJ; van de Ven AC; de Herder WW; Dekkers OM; Zandee WT; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    Front Endocrinol (Lausanne); 2022; 13():926491. PubMed ID: 36277719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EUS-guided FNA cytology of pancreatic neuroendocrine tumour (PanNET): a retrospective study of 132 cases over an 18-year period in a single institution.
    Chen S; Lin J; Wang X; Wu HH; Cramer H
    Cytopathology; 2014 Dec; 25(6):396-403. PubMed ID: 24635775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based Cohort.
    van Beek DJ; Verkooijen HM; Nell S; Bonsing BA; van Eijck CH; van Goor H; Hoogwater FJH; Nieveen van Dijkum EJM; Kazemier G; Dejong CHC; Brosens LAA; Wessels FJ; Borel Rinkes IHM; Valk GD; Vriens MR
    Neuroendocrinology; 2021; 111(8):705-717. PubMed ID: 32721974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic imaging in MEN1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
    Kostiainen I; Majala S; Schildt J; Parviainen H; Kauhanen S; Seppänen H; Miettinen PJ; Matikainen N; Ryhänen EM; Schalin-Jäntti C
    Eur J Endocrinol; 2023 May; 188(5):421-429. PubMed ID: 36943311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
    Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
    World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Endoscopic Ultrasound in Detecting Pancreatic Cancer Missed on Cross-Sectional Imaging in Patients Presenting with Pancreatitis: A Retrospective Review.
    Bartell N; Bittner K; Vetter MS; Kothari T; Kaul V; Kothari S
    Dig Dis Sci; 2019 Dec; 64(12):3623-3629. PubMed ID: 31529412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
    Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
    Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct.
    Agarwal B; Krishna NB; Labundy JL; Safdar R; Akduman EI
    Gastrointest Endosc; 2008 Aug; 68(2):237-42; quiz 334, 335. PubMed ID: 18423464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
    Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of EUS-guided fine needle aspiration (EUS-FNA) in the diagnosis of functioning neuroendocrine tumors.
    Ginès A; Vazquez-Sequeiros E; Soria MT; Clain JE; Wiersema MJ
    Gastrointest Endosc; 2002 Aug; 56(2):291-6. PubMed ID: 12145615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-harmonic endoscopic ultrasound for the diagnosis of pancreatic adenocarcinoma: a prospective multicenter trial.
    Gincul R; Palazzo M; Pujol B; Tubach F; Palazzo L; Lefort C; Fumex F; Lombard A; Ribeiro D; Fabre M; Hervieu V; Labadie M; Ponchon T; Napoléon B
    Endoscopy; 2014 May; 46(5):373-9. PubMed ID: 24532350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of EUS-FNA in patients suspected of having pancreatic cancer with a focal lesion on CT scan/MRI but without obstructive jaundice.
    Krishna NB; LaBundy JL; Saripalli S; Safdar R; Agarwal B
    Pancreas; 2009 Aug; 38(6):625-30. PubMed ID: 19506529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms.
    Hijioka S; Hara K; Mizuno N; Imaoka H; Bhatia V; Mekky MA; Yoshimura K; Yoshida T; Okuno N; Hieda N; Tajika M; Tanaka T; Ishihara M; Yatabe Y; Shimizu Y; Niwa Y; Yamao K
    J Gastroenterol; 2016 Sep; 51(9):923-30. PubMed ID: 26768605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience.
    Atiq M; Bhutani MS; Bektas M; Lee JE; Gong Y; Tamm EP; Shah CP; Ross WA; Yao J; Raju GS; Wang X; Lee JH
    Dig Dis Sci; 2012 Mar; 57(3):791-800. PubMed ID: 21964743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors.
    Paiella S; Impellizzeri H; Zanolin E; Marchegiani G; Miotto M; Malpaga A; De Robertis R; D'Onofrio M; Rusev B; Capelli P; Cingarlini S; Butturini G; Davì MV; Amodio A; Bassi C; Scarpa A; Salvia R; Landoni L
    World J Gastroenterol; 2017 May; 23(17):3092-3098. PubMed ID: 28533666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
    Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
    Kornaczewski Jackson ER; Pointon OP; Bohmer R; Burgess JR
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1926-1933. PubMed ID: 28323985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Imaging or Endoscopic Ultrasonography for Detection and Surveillance of Pancreatic Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1?
    Daskalakis K; Tsoli M; Alexandraki KI; Angelousi A; Chatzellis E; Tsolakis AV; Karoumpalis I; Kolomodi D; Kassi E; Kaltsas G
    Horm Metab Res; 2019 Sep; 51(9):580-585. PubMed ID: 31295747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rupture of small cystic pancreatic neuroendocrine tumor with many microtumors.
    Sagami R; Nishikiori H; Ikuyama S; Murakami K
    World J Gastroenterol; 2017 Oct; 23(37):6911-6919. PubMed ID: 29085235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases.
    Paiella S; Landoni L; Rota R; Valenti M; Elio G; Crinò SF; Manfrin E; Parisi A; Cingarlini S; D'Onofrio M; Scarpa A; Lawlor RT; Bernardoni L; Capelli P; Nessi C; Miotto M; Gabbrielli A; Bassi C; Salvia R
    Endoscopy; 2020 Nov; 52(11):988-994. PubMed ID: 32498099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.